These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 310745)
21. Role of TGF-beta and PGE2 in T cell responses during Plasmodium yoelii infection. Ocaña-Morgner C; Wong KA; Lega F; Dotor J; Borras-Cuesta F; Rodriguez A Eur J Immunol; 2007 Jun; 37(6):1562-74. PubMed ID: 17474154 [TBL] [Abstract][Full Text] [Related]
22. Anti-lymphocyte antibodies in lethal mouse malaria. II. Induction of an autoantibody specific suppressor T cell by non-lethal P. yoelii. de Souza JB; Playfair JH Clin Exp Immunol; 1983 Oct; 54(1):110-6. PubMed ID: 6225580 [TBL] [Abstract][Full Text] [Related]
23. Lack of correlation between delayed-type hypersensitivity and host resistance to Plasmodium chabaudi infection. McDonald V; Sherman IW Clin Exp Immunol; 1980 Dec; 42(3):421-7. PubMed ID: 7011608 [TBL] [Abstract][Full Text] [Related]
24. Defective vaccine-induced immunity to Schistosoma mansoni in P strain mice. II. Analysis of cellular responses. James SL; Correa-Oliveira R; Leonard EJ J Immunol; 1984 Sep; 133(3):1587-93. PubMed ID: 6431002 [TBL] [Abstract][Full Text] [Related]
25. Effects of immune complexes on immunity to Plasmodium berghei infection. Alder JD; Kreier JP Tropenmed Parasitol; 1984 Dec; 35(4):253-9. PubMed ID: 6395456 [TBL] [Abstract][Full Text] [Related]
26. Gamma delta T cells function in cell-mediated immunity to acute blood-stage Plasmodium chabaudi adami malaria. van der Heyde HC; Elloso MM; Chang WL; Kaplan M; Manning DD; Weidanz WP J Immunol; 1995 Apr; 154(8):3985-90. PubMed ID: 7706737 [TBL] [Abstract][Full Text] [Related]
27. Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells. Tarun AS; Dumpit RF; Camargo N; Labaied M; Liu P; Takagi A; Wang R; Kappe SH J Infect Dis; 2007 Aug; 196(4):608-16. PubMed ID: 17624848 [TBL] [Abstract][Full Text] [Related]
28. Plasmodium: mammalian codon optimization of malaria plasmid DNA vaccines enhances antibody responses but not T cell responses nor protective immunity. Dobaño C; Sedegah M; Rogers WO; Kumar S; Zheng H; Hoffman SL; Doolan DL Exp Parasitol; 2009 Jun; 122(2):112-23. PubMed ID: 19249301 [TBL] [Abstract][Full Text] [Related]
29. T cell responses induced by the parenteral injection of antigen-modified syngeneic cells. I. Induction, characterization, and regulation of antigen-specific T helper cells involved in delayed-type hypersensitivity responses. Miller SD; Butler LD J Immunol; 1983 Jul; 131(1):77-85. PubMed ID: 6190929 [TBL] [Abstract][Full Text] [Related]
30. Association of intermediate T cell receptor cells, mainly their NK1.1(-) subset, with protection from malaria. Weerasinghe A; Sekikawa H; Watanabe H; Mannoor K; Morshed SR; Halder RC; Kawamura T; Kosaka T; Miyaji C; Kawamura H; Seki S; Abo T Cell Immunol; 2001 Jan; 207(1):28-35. PubMed ID: 11161450 [TBL] [Abstract][Full Text] [Related]
31. Immunological studies in rodent malaria. I: Protective immunity induced in mice by mild strains of Plasmodium berghei yoelii against a virulent and fatal line of this plasmodium. Hargreaves J; Yoeli M; Nussenzweig RS Ann Trop Med Parasitol; 1975 Sep; 69(3):289-99. PubMed ID: 1098589 [TBL] [Abstract][Full Text] [Related]
32. Lymphocyte traffic and lymphocyte destruction in murine malaria. Playfair JH; de Souza JB Immunology; 1982 May; 46(1):125-33. PubMed ID: 7042547 [TBL] [Abstract][Full Text] [Related]
33. Delayed-type hypersensitivity initiation by early-acting cells that are antigen mismatched or MHC incompatible with late-acting, delayed-type hypersensitivity effector T cells. Ptak W; Herzog WR; Askenase PW J Immunol; 1991 Jan; 146(2):469-75. PubMed ID: 1987274 [TBL] [Abstract][Full Text] [Related]
34. MHC class I-dependent presentation of exoerythrocytic antigens to CD8+ T lymphocytes is required for protective immunity against Plasmodium berghei. White KL; Snyder HL; Krzych U J Immunol; 1996 May; 156(9):3374-81. PubMed ID: 8617963 [TBL] [Abstract][Full Text] [Related]
35. Simultaneous increases in immune-competent cells and nitric oxide in the spleen during Plasmodium berghei infection in mice. Nahrevanian H; Dascombe MJ J Microbiol Immunol Infect; 2006 Feb; 39(1):11-7. PubMed ID: 16440118 [TBL] [Abstract][Full Text] [Related]
36. Immunoregulation in murine malaria. Susceptibility of inbred mice to infection with Plasmodium yoelii depends on the dynamic interplay of host and parasite genes. Sayles PC; Wassom DL J Immunol; 1988 Jul; 141(1):241-8. PubMed ID: 3379305 [TBL] [Abstract][Full Text] [Related]
37. B lymphocytes are required for the generation of T cells that mediate healing of cutaneous leishmaniasis. Scott P; Natovitz P; Sher A J Immunol; 1986 Aug; 137(3):1017-21. PubMed ID: 3487581 [TBL] [Abstract][Full Text] [Related]
38. Interdependence of CD4+ T cells and malarial spleen in immunity to Plasmodium vinckei vinckei. Relevance to vaccine development. Kumar S; Good MF; Dontfraid F; Vinetz JM; Miller LH J Immunol; 1989 Sep; 143(6):2017-23. PubMed ID: 2570802 [TBL] [Abstract][Full Text] [Related]
39. The role of the liver in immunity to blood-stage murine malaria. Dockrell HM; de Souza JB; Playfair JH Immunology; 1980 Oct; 41(2):421-30. PubMed ID: 7439934 [TBL] [Abstract][Full Text] [Related]
40. Alteration of bone marrow cell cycle kinetics by diphenylhydantoin: relationship to folate utilization and immune function. Tucker AN; Hong L; Boorman GA; Pung O; Luster MI J Pharmacol Exp Ther; 1985 Jul; 234(1):57-62. PubMed ID: 4009505 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]